Keywords: isis, shares, macugen, royalties, pharmaceuticals, sold, portion

Isis to shares Macugen royalties for $24 M

Article | 10 January 2005

Print This

Isis Pharmaceuticals has sold a portion of its royalty rights in Macugen (pegaptanib sodium injection) to Drug Royalty USA for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in